Symbols / GERN
GERN Chart
About
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.24B |
| Enterprise Value | 986.18M | Income | -79.99M | Sales | 183.40M |
| Book/sh | 0.39 | Cash/sh | 0.60 | Dividend Yield | — |
| Payout | 0.00% | Employees | 229 | IPO | — |
| P/E | — | Forward P/E | -78.00 | PEG | — |
| P/S | 6.79 | P/B | 5.00 | P/C | — |
| EV/EBITDA | -15.76 | EV/Sales | 5.38 | Quick Ratio | 4.77 |
| Current Ratio | 5.96 | Debt/Eq | 49.02 | LT Debt/Eq | — |
| EPS (ttm) | -0.12 | EPS next Y | -0.03 | EPS Growth | — |
| Revenue Growth | 67.10% | Earnings | 2026-02-25 | ROA | -7.79% |
| ROE | -29.57% | ROIC | — | Gross Margin | 53.36% |
| Oper. Margin | -29.40% | Profit Margin | -43.61% | Shs Outstand | 638.36M |
| Shs Float | 541.48M | Short Float | 9.57% | Short Ratio | 5.57 |
| Short Interest | — | 52W High | 2.58 | 52W Low | 1.04 |
| Beta | 0.62 | Avg Volume | 10.71M | Volume | 23.83M |
| Target Price | $3.40 | Recom | Buy | Prev Close | $1.77 |
| Price | $1.95 | Change | 10.17% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$3.40
Mean price target
2. Current target
$1.95
Latest analyst target
3. DCF / Fair value
$-2.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.95
Low
$1.00
High
$5.00
Mean
$3.40
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-05 | main | Needham | Buy → Buy | $4 |
| 2025-05-08 | down | Scotiabank | Sector Outperform → Sector Perform | $2 |
| 2025-03-12 | reit | Needham | Buy → Buy | $5 |
| 2025-03-12 | reit | HC Wainwright & Co. | Neutral → Neutral | — |
| 2025-02-27 | main | Scotiabank | Sector Outperform → Sector Outperform | $4 |
| 2025-02-27 | main | Stifel | Buy → Buy | $4 |
| 2025-02-27 | main | Barclays | Overweight → Overweight | $4 |
| 2025-02-27 | main | Needham | Buy → Buy | $5 |
| 2025-02-26 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2025-02-18 | main | B. Riley Securities | Buy → Buy | $4 |
| 2025-01-13 | main | Needham | Buy → Buy | $7 |
| 2024-12-13 | reit | Needham | Buy → Buy | $6 |
| 2024-12-10 | reit | HC Wainwright & Co. | Buy → Buy | $9 |
| 2024-11-06 | reit | HC Wainwright & Co. | Buy → Buy | $8 |
| 2024-11-05 | init | HC Wainwright & Co. | — → Buy | $8 |
| 2024-10-16 | init | Scotiabank | — → Sector Outperform | $6 |
| 2024-09-09 | init | Leerink Partners | — → Outperform | $7 |
| 2024-08-09 | reit | Needham | Buy → Buy | $6 |
| 2024-07-26 | reit | Needham | Buy → Buy | $6 |
| 2024-06-11 | init | Barclays | — → Overweight | $9 |
- Assessing Geron (GERN) Valuation After Recent Short Term Share Price Momentum - Yahoo Finance Wed, 25 Feb 2026 04
- Geron Corporation (GERN) Stock Analysis: An Insight into the Biotech Player’s 77% Potential Upside - DirectorsTalk Interviews Sat, 21 Feb 2026 05
- Geron Stock: Under-Promise And Over-Deliver Could Be The 2026 Strategy (GERN) - Seeking Alpha ue, 27 Jan 2026 08
- Is Geron (GERN) Pricing Look Attractive After Recent Share Price Rebound? - Yahoo Finance ue, 24 Feb 2026 17
- Geron Corporation's (NASDAQ:GERN) Prospects Need A Boost To Lift Shares - simplywall.st ue, 03 Feb 2026 08
- Geron Corporation Q4 Financial Announcement Sparks Investor Curiosity - StocksToTrade ue, 24 Feb 2026 17
- Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT - Insider Monkey Mon, 23 Feb 2026 15
- Geron (NASDAQ: GERN) cuts operating expense outlook to $250–$260M; IMpactMF enrollment done - Stock Titan Wed, 05 Nov 2025 08
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Wed, 18 Feb 2026 21
- Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT - Bitget Mon, 23 Feb 2026 15
- Assessing Geron (GERN) Valuation After 2026 RYTELO Revenue Outlook And Pipeline Progress - simplywall.st ue, 24 Feb 2026 03
- Geron (Nasdaq: GERN) plans one-third cut as 2026 operating expenses expected below 2025 - Stock Titan hu, 11 Dec 2025 08
- Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT - Yahoo Finance Mon, 23 Feb 2026 14
- TD Cowen Maintains Buy Rating for Geron (GERN) While Trimming PT to $3 Ahead of Q4 Results - Yahoo Finance Fri, 30 Jan 2026 08
- Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Yahoo Finance hu, 11 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 9855 | 19119.0 | — | Sale at price 1.94 per share. | ROBERTSON MICHELLE | Chief Financial Officer | — | 2026-02-18 00:00:00 | D |
| 1 | 27500 | nan | — | — | ROBERTSON MICHELLE | Chief Financial Officer | — | 2026-02-18 00:00:00 | D |
| 2 | 5918 | 7812.0 | — | Stock Award(Grant) at price 1.32 per share. | SPIEGEL ROBERT J | Director | — | 2025-12-31 00:00:00 | D |
| 3 | 5702 | 7812.0 | — | Stock Award(Grant) at price 1.37 per share. | SPIEGEL ROBERT J | Director | — | 2025-09-30 00:00:00 | D |
| 4 | 5540 | 7811.0 | — | Stock Award(Grant) at price 1.41 per share. | SPIEGEL ROBERT J | Director | — | 2025-06-30 00:00:00 | D |
| 5 | 13300 | 15667.0 | — | Purchase at price 1.18 per share. | LAWLIS VIRGIL BRYAN JR. | Director | — | 2025-05-09 00:00:00 | D |
| 6 | 4913 | 7812.0 | — | Stock Award(Grant) at price 1.59 per share. | SPIEGEL ROBERT J | Director | — | 2025-03-31 00:00:00 | D |
| 7 | 15000 | 24150.0 | — | Purchase at price 1.61 per share. | SAMUELS SCOTT ALAN | Officer | — | 2025-02-27 00:00:00 | D |
| 8 | 100000 | 160000.0 | — | Purchase at price 1.60 per share. | ZIEGLER JAMES | Officer | — | 2025-02-27 00:00:00 | D |
| 9 | 12500 | 22062.0 | — | Purchase at price 1.76 per share. | SCARLETT JOHN A | Chief Executive Officer | — | 2025-02-27 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -153.14M | -174.78M | -134.15M | -111.59M |
| TotalUnusualItems | -1.71M | 0.00 | 0.00 | |
| TotalUnusualItemsExcludingGoodwill | -1.71M | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -174.57M | -184.13M | -141.90M | -116.11M |
| ReconciledDepreciation | 1.22M | 1.03M | 868.00K | 783.00K |
| ReconciledCostOfRevenue | 1.26M | 0.00 | 0.00 | |
| EBITDA | -154.85M | -174.78M | -134.15M | -111.59M |
| EBIT | -156.07M | -175.81M | -135.02M | -112.37M |
| NetInterestIncome | 1.10M | 9.84M | -4.35M | -3.21M |
| InterestExpense | 18.50M | 8.31M | 6.88M | 3.74M |
| InterestIncome | 19.61M | 18.15M | 2.53M | 527.00K |
| NormalizedIncome | -172.87M | -184.13M | -141.90M | -116.11M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -174.57M | -184.13M | -141.90M | -116.11M |
| TotalExpenses | 250.73M | 194.18M | 139.15M | 115.39M |
| TotalOperatingIncomeAsReported | -173.73M | -193.94M | -138.55M | -114.00M |
| DilutedAverageShares | 646.03M | 570.65M | 380.78M | 327.63M |
| BasicAverageShares | 646.03M | 570.65M | 380.78M | 327.63M |
| DilutedEPS | -0.27 | -0.32 | -0.37 | -0.35 |
| BasicEPS | -0.27 | -0.32 | -0.37 | -0.35 |
| DilutedNIAvailtoComStockholders | -174.57M | -184.13M | -141.90M | -116.11M |
| NetIncomeCommonStockholders | -174.57M | -184.13M | -141.90M | -116.11M |
| NetIncome | -174.57M | -184.13M | -141.90M | -116.11M |
| NetIncomeIncludingNoncontrollingInterests | -174.57M | -184.13M | -141.90M | -116.11M |
| NetIncomeContinuousOperations | -174.57M | -184.13M | -141.90M | -116.11M |
| PretaxIncome | -174.57M | -184.13M | -141.90M | -116.11M |
| OtherIncomeExpense | -1.94M | -23.00K | 1.00M | 1.10M |
| OtherNonOperatingIncomeExpenses | -236.00K | -23.00K | 1.00M | 1.10M |
| SpecialIncomeCharges | -1.71M | 0.00 | 0.00 | |
| OtherSpecialCharges | 1.71M | |||
| NetNonOperatingInterestIncomeExpense | 1.10M | 9.84M | -4.35M | -3.21M |
| InterestExpenseNonOperating | 18.50M | 8.31M | 6.88M | 3.74M |
| InterestIncomeNonOperating | 19.61M | 18.15M | 2.53M | 527.00K |
| OperatingIncome | -173.73M | -193.94M | -138.55M | -114.00M |
| OperatingExpense | 249.47M | 194.18M | 139.15M | 115.39M |
| ResearchAndDevelopment | 103.74M | 125.05M | 95.52M | 85.73M |
| SellingGeneralAndAdministration | 145.73M | 69.14M | 43.63M | 29.66M |
| GeneralAndAdministrativeExpense | 145.73M | 69.14M | 43.63M | 29.66M |
| OtherGandA | 145.73M | 69.14M | 43.63M | 29.66M |
| GrossProfit | 75.74M | 237.00K | 596.00K | |
| CostOfRevenue | 1.26M | 0.00 | 0.00 | |
| TotalRevenue | 76.99M | 237.00K | 596.00K | 1.39M |
| OperatingRevenue | 89.92M | 237.00K | 596.00K | 1.39M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 606.39M | 544.91M | 390.26M | 323.73M |
| ShareIssued | 606.39M | 544.91M | 390.26M | 323.73M |
| NetDebt | 39.46M | 11.92M | 14.96M | |
| TotalDebt | 121.72M | 85.90M | 55.75M | 55.00M |
| TangibleBookValue | 280.32M | 247.95M | 80.00M | 126.42M |
| InvestedCapital | 398.80M | 329.89M | 131.16M | 176.25M |
| WorkingCapital | 402.69M | 233.28M | 103.55M | 141.69M |
| NetTangibleAssets | 280.32M | 247.95M | 80.00M | 126.42M |
| CapitalLeaseObligations | 3.24M | 3.96M | 4.60M | 5.17M |
| CommonStockEquity | 280.32M | 247.95M | 80.00M | 126.42M |
| TotalCapitalization | 398.80M | 283.00M | 110.21M | 176.25M |
| TotalEquityGrossMinorityInterest | 280.32M | 247.95M | 80.00M | 126.42M |
| StockholdersEquity | 280.32M | 247.95M | 80.00M | 126.42M |
| GainsLossesNotAffectingRetainedEarnings | 261.00K | 185.00K | -219.00K | -173.00K |
| OtherEquityAdjustments | 261.00K | 185.00K | -219.00K | -173.00K |
| RetainedEarnings | -1.77B | -1.60B | -1.41B | -1.27B |
| AdditionalPaidInCapital | 2.05B | 1.84B | 1.49B | 1.40B |
| CapitalStock | 606.00K | 545.00K | 390.00K | 324.00K |
| CommonStock | 606.00K | 545.00K | 390.00K | 324.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 313.46M | 146.13M | 110.58M | 99.62M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 225.16M | 38.06M | 33.88M | 54.10M |
| OtherNonCurrentLiabilities | 104.42M | |||
| LongTermDebtAndCapitalLeaseObligation | 120.74M | 38.06M | 33.88M | 54.10M |
| LongTermCapitalLeaseObligation | 2.27M | 3.01M | 3.67M | 4.27M |
| LongTermDebt | 118.48M | 35.05M | 30.21M | 49.83M |
| CurrentLiabilities | 88.30M | 108.07M | 76.69M | 45.52M |
| OtherCurrentLiabilities | 20.37M | |||
| CurrentDebtAndCapitalLeaseObligation | 974.00K | 47.84M | 21.87M | 901.00K |
| CurrentCapitalLeaseObligation | 974.00K | 949.00K | 925.00K | 901.00K |
| CurrentDebt | 46.89M | 20.95M | ||
| OtherCurrentBorrowings | 46.89M | 20.95M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 22.81M | 13.76M | 11.53M | 8.10M |
| PayablesAndAccruedExpenses | 44.14M | 46.47M | 43.29M | 36.52M |
| CurrentAccruedExpenses | 35.55M | 40.31M | 33.10M | 29.83M |
| InterestPayable | 2.19M | 768.00K | 561.00K | 336.00K |
| Payables | 8.60M | 6.16M | 10.19M | 6.69M |
| AccountsPayable | 8.60M | 6.16M | 10.19M | 6.69M |
| TotalAssets | 593.78M | 394.08M | 190.57M | 226.03M |
| TotalNonCurrentAssets | 102.79M | 52.73M | 10.33M | 38.83M |
| OtherNonCurrentAssets | 4.08M | 4.70M | 5.39M | 4.80M |
| NonCurrentPrepaidAssets | 5.39M | 4.80M | ||
| InvestmentsAndAdvances | 94.52M | 43.30M | 0.00 | 28.65M |
| InvestmentinFinancialAssets | 94.52M | 43.30M | 0.00 | 28.65M |
| AvailableForSaleSecurities | 94.52M | 43.30M | 28.65M | |
| NetPPE | 4.19M | 4.73M | 4.94M | 5.38M |
| AccumulatedDepreciation | -1.70M | -1.23M | -896.00K | -650.00K |
| GrossPPE | 5.89M | 5.96M | 5.84M | 6.03M |
| Leases | 129.00K | 135.00K | 135.00K | 129.00K |
| MachineryFurnitureEquipment | 2.88M | 2.27M | 1.55M | 1.17M |
| BuildingsAndImprovements | 2.88M | 3.56M | 4.15M | 4.73M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 490.99M | 341.35M | 180.25M | 187.21M |
| OtherCurrentAssets | 5.05M | 4.88M | 3.99M | 1.36M |
| RestrictedCash | 1.86M | 1.11M | 364.00K | 364.00K |
| PrepaidAssets | 1.36M | |||
| Inventory | 38.71M | 0.00 | ||
| FinishedGoods | 3.72M | 0.00 | ||
| WorkInProcess | 30.09M | |||
| RawMaterials | 4.90M | |||
| Receivables | 38.80M | 1.66M | 3.14M | 1.76M |
| AccruedInterestReceivable | 2.85M | 1.66M | 3.14M | 1.76M |
| AccountsReceivable | 35.95M | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 406.57M | 333.70M | 172.75M | 183.72M |
| OtherShortTermInvestments | 327.55M | 263.68M | 115.90M | 148.85M |
| CashAndCashEquivalents | 79.02M | 70.02M | 56.84M | 34.87M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -219.30M | -168.57M | -127.81M | -95.76M |
| RepaymentOfDebt | -86.55M | 0.00 | 0.00 | |
| IssuanceOfDebt | 121.12M | 29.70M | 0.00 | 24.89M |
| IssuanceOfCapitalStock | 140.73M | 213.34M | 69.92M | 20.39M |
| CapitalExpenditure | -680.00K | -830.00K | -431.00K | -207.00K |
| EndCashPosition | 80.88M | 71.14M | 57.21M | 35.23M |
| BeginningCashPosition | 71.14M | 57.21M | 35.23M | 10.29M |
| EffectOfExchangeRateChanges | -12.00K | -27.00K | 22.00K | 0.00 |
| ChangesInCash | 9.75M | 13.96M | 21.95M | 24.95M |
| FinancingCashFlow | 334.37M | 362.02M | 87.26M | 48.56M |
| CashFlowFromContinuingFinancingActivities | 334.37M | 362.02M | 87.26M | 48.56M |
| NetOtherFinancingCharges | 125.00M | |||
| ProceedsFromStockOptionExercised | 34.08M | 118.98M | 17.35M | 3.28M |
| NetCommonStockIssuance | 140.73M | 213.34M | 69.92M | 20.39M |
| CommonStockIssuance | 140.73M | 213.34M | 69.92M | 20.39M |
| NetIssuancePaymentsOfDebt | 34.57M | 29.70M | 0.00 | 24.89M |
| NetLongTermDebtIssuance | 34.57M | 29.70M | 0.00 | 24.89M |
| LongTermDebtPayments | -86.55M | 0.00 | 0.00 | |
| LongTermDebtIssuance | 121.12M | 29.70M | 0.00 | 24.89M |
| InvestingCashFlow | -106.00M | -180.32M | 62.07M | 71.95M |
| CashFlowFromContinuingInvestingActivities | -106.00M | -180.32M | 62.07M | 71.95M |
| NetInvestmentPurchaseAndSale | -105.32M | -179.49M | 62.50M | 72.15M |
| SaleOfInvestment | 371.61M | 296.10M | 320.50M | 249.59M |
| PurchaseOfInvestment | -476.93M | -475.59M | -258.01M | -177.43M |
| NetBusinessPurchaseAndSale | 1.59M | |||
| SaleOfBusiness | 1.59M | |||
| NetPPEPurchaseAndSale | -680.00K | -830.00K | -431.00K | -207.00K |
| PurchaseOfPPE | -680.00K | -830.00K | -431.00K | -207.00K |
| OperatingCashFlow | -218.62M | -167.74M | -127.38M | -95.56M |
| CashFlowFromContinuingOperatingActivities | -218.62M | -167.74M | -127.38M | -95.56M |
| ChangeInWorkingCapital | -68.41M | 6.06M | 5.03M | 10.52M |
| ChangeInOtherWorkingCapital | 9.05M | 2.22M | 3.44M | -119.00K |
| ChangeInOtherCurrentLiabilities | -715.00K | -640.00K | -572.00K | -509.00K |
| ChangeInPayablesAndAccruedExpense | -2.32M | 3.18M | 6.77M | 14.68M |
| ChangeInAccruedExpense | -4.76M | 7.21M | 3.27M | 14.91M |
| ChangeInPayable | 2.44M | -4.03M | 3.50M | -232.00K |
| ChangeInAccountPayable | 2.44M | -4.03M | 3.50M | -232.00K |
| ChangeInPrepaidAssets | 443.00K | -194.00K | -3.22M | -2.49M |
| ChangeInInventory | -37.97M | 0.00 | 0.00 | |
| ChangeInReceivables | -36.89M | 1.49M | -1.38M | -1.04M |
| ChangesInAccountReceivables | -35.70M | 0.00 | 0.00 | |
| OtherNonCashItems | -5.29M | 1.09M | 1.33M | 893.00K |
| StockBasedCompensation | 31.32M | 19.35M | 8.27M | 8.17M |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | 0.00 | ||
| ProvisionandWriteOffofAssets | -251.00K | 0.00 | 0.00 | |
| AmortizationOfSecurities | -9.68M | -11.15M | -965.00K | 1.42M |
| DepreciationAmortizationDepletion | 1.22M | 1.03M | 868.00K | 783.00K |
| DepreciationAndAmortization | 1.22M | 1.03M | 868.00K | 783.00K |
| Depreciation | 1.22M | 1.03M | 868.00K | 783.00K |
| OperatingGainsLosses | 7.05M | -1.23M | ||
| PensionAndEmployeeBenefitExpense | 5.34M | 0.00 | 0.00 | 0.00 |
| EarningsLossesFromEquityInvestments | 0.00 | |||
| GainLossOnInvestmentSecurities | -1.23M | |||
| NetIncomeFromContinuingOperations | -174.57M | -184.13M | -141.90M | -116.11M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for GERN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|